Reliable Characterization of Organic & Pharmaceutical Compounds with High Resolution Monochromated EEL Spectroscopy

dc.contributor.author
Das, Partha Pratim
dc.contributor.author
Guzzinati, Giulio
dc.contributor.author
Coll, Cristina
dc.contributor.author
Gómez Pérez, Alejandro
dc.contributor.author
Nicolopoulos, Stavros
dc.contributor.author
Estradé Albiol, Sònia
dc.contributor.author
Peiró Martínez, Francisca
dc.contributor.author
Verbeeck, Johan
dc.contributor.author
Zompra, Aikaterini A.
dc.contributor.author
Galanis, Athanassios S.
dc.date.issued
2021-04-15T09:10:18Z
dc.date.issued
2021-04-15T09:10:18Z
dc.date.issued
2020-06-27
dc.date.issued
2021-04-15T09:10:18Z
dc.identifier
2073-4360
dc.identifier
https://hdl.handle.net/2445/176302
dc.identifier
708791
dc.identifier
32605004
dc.description.abstract
Organic and biological compounds (especially those related to the pharmaceutical industry) have always been of great interest for researchers due to their importance for the development of new drugs to diagnose, cure, treat or prevent disease. As many new API (active pharmaceutical ingredients) and their polymorphs are in nanocrystalline or in amorphous form blended with amorphous polymeric matrix (known as amorphous solid dispersion-ASD), their structural identification and characterization at nm scale with conventional X-Ray/Raman/IR techniques becomes difficult. During any API synthesis/production or in the formulated drug product, impurities must be identified and characterized. Electron energy loss spectroscopy (EELS) at high energy resolution by transmission electron microscope (TEM) is expected to be a promising technique to screen and identify the different (organic) compounds used in a typical pharmaceutical or biological system and to detect any impurities present, if any, during the synthesis or formulation process. In this work, we propose the use of monochromated TEM-EELS, to analyze selected peptides and organic compounds and their polymorphs. In order to validate EELS for fingerprinting (in low loss/optical region) and by further correlation with advanced DFT, simulations were utilized.
dc.format
11 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
MDPI
dc.relation
Reproducció del document publicat a: https://doi.org/10.3390/polym12071434
dc.relation
Polymers, 2020, vol. 12, num. 7, p. 1434
dc.relation
https://doi.org/10.3390/polym12071434
dc.relation
info:eu-repo/grantAgreement/EC/H2020/731019/EU//EUSMI
dc.rights
cc-by (c) Das, Partha Pratim et al., 2020
dc.rights
http://creativecommons.org/licenses/by/3.0/es
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Enginyeria Electrònica i Biomèdica)
dc.subject
Indústria farmacèutica
dc.subject
Daltonisme
dc.subject
Pharmaceutical industry
dc.subject
Color blindness
dc.title
Reliable Characterization of Organic & Pharmaceutical Compounds with High Resolution Monochromated EEL Spectroscopy
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Fitxers en aquest element

FitxersGrandàriaFormatVisualització

No hi ha fitxers associats a aquest element.

Aquest element apareix en la col·lecció o col·leccions següent(s)